ACETYLATOR PHENOTYPING - A COMPARISON OF THE ISONIAZID AND DAPSONE TESTS

被引：42

作者：

HANSON, A

MELANDER, A

WAHLINBOLL, E

机构：

[1] UNIV LUND,MALMO GEN HOSP,DEPT CLIN PHARMACOL,S-21401 MALMO,SWEDEN

[2] DEPT COMMUNITY CARE SCI,DALBY,SWEDEN

来源：

关键词：

D O I：

10.1007/BF00544604

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：233 / 234

页数：2

共 9 条

[1] BOOBIS AR, 1979, DRUG TOXICITY, P50
[2] CARR K, 1978, BRIT J CLIN PHARMACO, V6, P421, DOI 10.1111/j.1365-2125.1978.tb04606.x
[3] EVANS DAP, 1964, J LAB CLIN MED, V63, P394
[4] GELBER R, 1971, CLIN PHARMACOL THER, V12, P225
[5] DISEASE AND ACETYLATION POLYMORPHISM
LUNDE, PKM
FRISLID, K
HANSTEEN, V
[J]. CLINICAL PHARMACOKINETICS, 1977, 2 (03) : 182 - 197
[6] MAHER JR, 1957, AM REV TUBERC PULM, V76, P852
[7] MITCHELL JR, 1975, CLIN PHARMACOL THER, V18, P70
[8] REIDENBERG MM, 1975, CLIN PHARMACOL THER, V17, P722
[9] WEBER WW, 1973, METAB CONJUGATION, V3, P250